Gary H Lyman
Overview
Explore the profile of Gary H Lyman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
436
Citations
18763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
4.
5.
Lyman G, Lyman C, Kuderer N
Cancer Invest
. 2024 Feb;
42(5):361-364.
PMID: 38303557
No abstract available.
6.
Krychtiuk K, Andersson T, Bodesheim U, Butler J, Curtis L, Elkind M, et al.
Am Heart J
. 2024 Jan;
270:23-43.
PMID: 38242417
The global pharmaceutical industry portfolio is skewed towards cancer and rare diseases due to more predictable development pathways and financial incentives. In contrast, drug development for major chronic health conditions...
7.
Lyman G, Lyman C, Kuderer N
Cancer Invest
. 2024 Jan;
42(4):275-277.
PMID: 38175037
No abstract available.
8.
Lyman G, Lyman C, Kuderer N
Cancer Invest
. 2023 Nov;
42(3):199-201.
PMID: 37933804
No abstract available.
9.
Nagaraj G, Vinayak S, Khaki A, Sun T, Kuderer N, Aboulafia D, et al.
Elife
. 2023 Oct;
12.
PMID: 37846664
Background: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. Methods: This is a COVID-19 and Cancer Consortium (CCC19)...
10.
Lyman G, Lyman C, Kuderer N
Cancer Invest
. 2023 Oct;
42(2):115-118.
PMID: 37818859
No abstract available.